Crossmark

Nr1d1 inhibition mitigates intermittent hypoxia-induced pulmonary hypertension via Dusp1-mediated Erk1/2 deactivation and mitochondrial fission attenuation

Crossref DOI link: https://doi.org/10.1038/s41420-024-02219-5

Published Online: 2024-10-29

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Pan, Zhou

Yao, Yan

Liu, Xu

Wang, Yixuan

Zhang, Xinyue

Zha, Shiqian

Hu, Ke https://orcid.org/0009-0002-6036-495X
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (82270101)
License Information

Text and Data Mining valid from 2024-10-29

Version of Record valid from 2024-10-29
More Information

Article History

Received: 8 March 2024

Revised: 30 September 2024

Accepted: 17 October 2024

First Online: 29 October 2024

Competing interests

: The authors declare no competing interests.

: The study followed the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals (Revised 1996) and the regulations of Renmin Hospital of Wuhan University Institutional Animal Care and Use Committee (IACUC Issue No. 20220723A).

Document is current

Any future updates will be listed below